1. 405 Impact of hyperthermic intraperitoneal chemotherapy (HIPEC) on tumor microenvironment (TME) in ovarian cancer – a subanalysis from a Phase I clinical trial. (13th November 2020) Authors: Dellinger, T; He, T; Lee, P; Guo, W; Cho, H; Wu, X; Liang, W; Schmolze, D; Razavi, M; Ruel, N; Han, E; Wakabayashi, M; Lee, S; Lin, WC; Kebria, M; Hakim, A; Cristea, M; Stewart, D; Wang, E; Raoof, M Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Expression of human endogenous retrovirus HERV-K18 is associated with clinical severity in osteoarthritis patients. (November 2013) Authors: Garcia-Montojo, M; Varade, J; Villafuertes, E; de La Hera, B; Hoyas-Fernandez, J; Domínguez-Mozo, MI; Rodriguez-Rodriguez, L; Tornero-Esteban, P; Arias-Leal, A; León, L; Lamas, JR; Alvarez-Lafuente, R; Urcelay, E; Fernandez-Gutierrez, B Journal: Scandinavian journal of rheumatology Issue: Volume 42:Number 6(2013) Page Start: 498 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0107 Development of a predictive model for rheumatoid arthritis mortality using random survival forest. (15th June 2017) Authors: Rodriguez-Rodriguez, L; Lezcano, JM; Soudah, E; Jover, JΆ; González-Άlvarez, I; Salazar, F; Abásolo, L Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 520 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis. (November 2013) Authors: Rodriguez-Rodriguez, L; Jover-Jover, JA; Fontsere, O; Peña-Blanco, RC; León, L; Fernández-Gutierrez, B; Abásolo, L Journal: Scandinavian journal of rheumatology Issue: Volume 42:Number 6(2013) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Leflunomide discontinuation in rheumatoid arthritis and influence of associated disease-modifying anti-rheumatic drugs: a survival analysis. (November 2013) Authors: Rodriguez-Rodriguez, L; Jover-Jover, JA; Fontsere, O; Peña-Blanco, RC; León, L; Fernández-Gutierrez, B; Abásolo, L Journal: Scandinavian journal of rheumatology Issue: Volume 42:Number 6(2013) Page Start: 433 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term drug survival of biological agents in patients with rheumatoid arthritis in clinical practice. (1st November 2016) Authors: Leon, L; Rodriguez-Rodriguez, L; Rosales, Z; Gomez, A; Lamas, JR; Pato, E; Jover, JA; Abasolo, L Journal: Scandinavian journal of rheumatology Issue: Volume 45:Number 6(2016) Page Start: 456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Observed and expected frequency of comorbid chronic diseases in rheumatic patients. Issue 3 (2nd November 2007) Authors: Loza, E; Jover, J A; Rodriguez-Rodriguez, L; Carmona, L Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 3(2008) Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗